123 related articles for article (PubMed ID: 29082741)
1. Point of care testing for paediatric coeliac disease in the new ESPGHAN era.
Lau MSY; Sanders DS
Rev Esp Enferm Dig; 2017 Nov; 109(11):741-742. PubMed ID: 29082741
[TBL] [Abstract][Full Text] [Related]
2. 'Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model'.
Lau MS; Mooney P; White W; Appleby V; Moreea S; Haythem I; Elias J; Bundhoo K; Corbett G; Wong L; Tsai HH; Cross S; Hebden J; Hoque S; Sanders D
BMC Gastroenterol; 2016 Sep; 16():115. PubMed ID: 27628523
[TBL] [Abstract][Full Text] [Related]
3. Increased Detection of Celiac Disease With Measurement of Deamidated Gliadin Peptide Antibody Before Endoscopy.
Mooney PD; Wong SH; Johnston AJ; Kurien M; Avgerinos A; Sanders DS
Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1278-1284.e1. PubMed ID: 25632807
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.
Agardh D
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1276-81. PubMed ID: 17683995
[TBL] [Abstract][Full Text] [Related]
5. Coeliac disease detection with an IgA/IgG-deamidated gliadin peptide based point of care test in community pharmacies.
Lau MS; Sanders DS
Int J Clin Pharm; 2019 Apr; 41(2):583-588. PubMed ID: 30778740
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies.
Sayed SK; Imam HM; Mahran AM; Refaiy AM
Egypt J Immunol; 2012; 19(2):41-52. PubMed ID: 23885406
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report.
Giersiepen K; Lelgemann M; Stuhldreher N; Ronfani L; Husby S; Koletzko S; Korponay-Szabó IR;
J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):229-41. PubMed ID: 22266486
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a point-of-care test based on deamidated gliadin peptides for the detection of celiac disease in pediatric patients.
Polanco I; Koester Weber T; Martínez-Ojinaga E; Molina M; Sarria J
Rev Esp Enferm Dig; 2017 Nov; 109(11):743-748. PubMed ID: 28950706
[TBL] [Abstract][Full Text] [Related]
9. Low Sensitivity of Simtomax Point of Care Test in Detection of Celiac Disease in a Prospective Multicenter Study.
Tangermann P; Branchi F; Itzlinger A; Aschenbeck J; Schubert S; Maul J; Liceni T; Schröder A; Heller F; Spitz W; Möhler U; Graefe U; Radke M; Trenkel S; Schmitt M; Loddenkemper C; Preiß JC; Ullrich R; Daum S; Siegmund B; Bojarski C; Schumann M
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1780-1787.e5. PubMed ID: 30267867
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients.
Mozo L; Gómez J; Escanlar E; Bousoño C; Gutiérrez C
J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):50-5. PubMed ID: 22197936
[TBL] [Abstract][Full Text] [Related]
11. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease.
Monzani A; Rapa A; Fonio P; Tognato E; Panigati L; Oderda G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):55-60. PubMed ID: 21694536
[TBL] [Abstract][Full Text] [Related]
12. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases.
Gatselis NK; Zachou K; Norman GL; Tzellas G; Speletas M; Gabeta S; Germenis A; Koukoulis GK; Dalekos GN
Clin Chim Acta; 2012 Oct; 413(19-20):1683-8. PubMed ID: 22643316
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of IgG anti-deamidated gliadin peptide antibody assays is comparable to IgA anti-tTG in celiac disease.
Vermeersch P; Geboes K; Mariën G; Hoffman I; Hiele M; Bossuyt X
Clin Chim Acta; 2010 Jul; 411(13-14):931-5. PubMed ID: 20171961
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Yield of Isolated Deamidated Gliadin Peptide Antibody Elevation for Celiac Disease.
Hoerter NA; Shannahan SE; Suarez J; Lewis SK; Green PHR; Leffler DA; Lebwohl B
Dig Dis Sci; 2017 May; 62(5):1272-1276. PubMed ID: 28161854
[TBL] [Abstract][Full Text] [Related]
15. Simtomax, a novel point of care test for coeliac disease.
Mooney PD; Kurien M; Sanders DS
Expert Opin Med Diagn; 2013 Nov; 7(6):645-51. PubMed ID: 24059495
[TBL] [Abstract][Full Text] [Related]
16. Interpretation of serological tests in the diagnosis of celiac disease: Anti-deamidated gliadin peptide antibodies revisited.
Zucchini L; Giusti D; Gatouillat G; Servettaz A; Tabary T; Barbe C; Pham BN
Autoimmunity; 2016 Sep; 49(6):414-420. PubMed ID: 27452003
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Coeliac Disease in Omani Adults with Iron Deficiency Anaemia of Unknown Cause: Case-finding study.
Ambusaidi S; Al Busaidi AM; Al Salmani A; Davidson R; Alshekaili J; Kindi MA; Al Kindi R
Sultan Qaboos Univ Med J; 2022 May; 22(2):262-267. PubMed ID: 35673297
[TBL] [Abstract][Full Text] [Related]
18. Serologic screening for celiac disease in children: a comparison between established assays and tests with deamidated gliadin-derived peptides plus conjugates for both IgA and IgG antibodies.
Aberg AK; Olcén P
APMIS; 2009 Nov; 117(11):808-13. PubMed ID: 19845531
[TBL] [Abstract][Full Text] [Related]
19. [Significance of a method for determination of deamidated gliadin peptide in the diagnosis of celiac disease].
Sabelnikova EA; Parfenov AI; Krums LM; Gudkova RB; Sagynbaeva VE; Bykova SV
Ter Arkh; 2014; 86(2):39-43. PubMed ID: 24772506
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against deamidated gliadin peptides and tissue transglutaminase for diagnosis of pediatric celiac disease.
Olen O; Gudjónsdóttir AH; Browaldh L; Hessami M; Elvin K; Liedberg AS; Neovius M; Grahnquist L
J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):695-700. PubMed ID: 22722680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
